1. Home
  2. CTSO vs PLSM Comparison

CTSO vs PLSM Comparison

Compare CTSO & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.37

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Logo Pulsenmore Ltd. Ordinary Shares

PLSM

Pulsenmore Ltd. Ordinary Shares

N/A

Current Price

$2.91

Market Cap

22.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTSO
PLSM
Founded
1997
2014
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
22.3M
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
CTSO
PLSM
Price
$0.37
$2.91
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
68.3K
40.3K
Earning Date
05-01-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$10.34
N/A
Revenue Next Year
$22.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.53
N/A
52 Week Low
$0.30
$2.75
52 Week High
$1.04
$12.97

Technical Indicators

Market Signals
Indicator
CTSO
PLSM
Relative Strength Index (RSI) 47.36 36.31
Support Level $0.36 N/A
Resistance Level $0.40 $3.82
Average True Range (ATR) 0.04 0.29
MACD -0.00 -0.00
Stochastic Oscillator 58.70 17.71

Price Performance

Historical Comparison
CTSO
PLSM

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.

Share on Social Networks: